Literature DB >> 630744

Surgical treatment of infective endocarditis in hemodialysis patients.

K J Lavelle, M M Dentino.   

Abstract

Congestive heart failure following infective endocarditis in hemodialysis patients has been uniformly fatal in patients treated with antibiotics alone. Thirteen patients on chronic hemodialysis have undergone replacement of the infected valve with an overall survival of 61%. The aortic valve was involved in 10 patients and Staphylococcus aureus the responsible organism in nine. Recurrent bacteremia occurred in two of the eight long-term survivors and was successfully treated with antibiotics in one patient and replacement of the prosthesis in the other. The surgical treatment of infective endocarditis in the hemodialysis patient is an acceptable mode of therapy and its application should not be hindered by reservations concerning operative feasibility or postoperative longevity. As in non-dialysis patients with infective endocarditis and congestive heart failure early operative intervention may substantially improve survival.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 630744

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

1.  Haemodialysis and haemofiltration on cardiopulmonary bypass.

Authors:  M Hakim; D Wheeldon; D W Bethune; B B Milstein; T A English; J Wallwork
Journal:  Thorax       Date:  1985-02       Impact factor: 9.139

2.  Infective Endocarditis in Patients with Kidney Failure: Chronic Dialysis and Kidney Transplant.

Authors:  James H.E. Ireland; James T. McCarthy
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.725

3.  Double valve replacement for infective endocarditis in a hemodialysis patient: a case report.

Authors:  K Kinoshita; M Hisahara; A Nakashima; K Tokunaga
Journal:  Jpn J Surg       Date:  1988-09

4.  Staphylococcal septicaemia, endocarditis, and osteomyelitis in dialysis and renal transplant patients.

Authors:  A Nicholls; N Edward; G R Catto
Journal:  Postgrad Med J       Date:  1980-09       Impact factor: 2.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.